Log In
Print
BCIQ
Print
Print this Print this
 

Mongersen (GED-0301)

  Manage Alerts
Collapse Summary General Information
Company Nogra Pharma Ltd.
DescriptionAntisense oligonucleotide targeting SMAD family member 7 (MADH7; SMAD7)
Molecular Target SMAD family member 7 (MADH7) (SMAD7)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationCrohn's disease
Indication DetailsTreat moderate to severe Crohn's disease (CD)
Regulatory Designation

Partner

Celgene Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today